Branched‐chain amino acids and type 2 diabetes: a bidirectional Mendelian randomization analysis
Obesity · 2024-02 · 32 (2) · 423-435
DOI: 10.1002/oby.23951 ↗Kurz gefasst
Fachartikel in der Zeitschrift Obesity, online erschienen am 25.01.2024. Verfasst von Jonathan D Mosley und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, Tennessee, USA. Hauptthemen laut MEDLINE: Amino Acids, Branched-Chain, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NIDDK NIH HHS, NIH HHS.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Objective
Genetic studies have suggested that the branched‐chain amino acids (BCAAs) valine, leucine, and isoleucine have a causal association with type 2 diabetes (T2D). However, inferences are based on a limited number of genetic loci associated with BCAAs.
Methods
Instrumental variables (IVs) for each BCAA were constructed and validated using large well‐powered data sets and their association with T2D was tested using a two‐sample inverse‐variance weighted Mendelian randomization approach. Sensitivity analyses were performed to ensure the accuracy of the findings. A reverse association was assessed using instrumental variables for T2D.
Results
Estimated effect sizes between BCAA IVs and T2D, excluding outliers, were as follows: valine (β = 0.14 change in log‐odds per SD change in valine, 95% CI: −0.06 to 0.33, p = 0.17), leucine (β = 0.15, 95% CI: −0.02 to 0.32, p = 0.09), and isoleucine (β = 0.13, 95% CI: −0.08 to 0.34, p = 0.24). In contrast, T2D IVs were positively associated with each BCAA, i.e., valine (β = 0.08 per SD change in levels per log‐odds change in T2D, 95% CI: 0.05 to 0.10, p = 1.8 × 10 −9 ), leucine (β = 0.06, 95% CI: 0.04 to 0.09, p = 4.5 × 10 −8 ), and isoleucine (β = 0.06, 95% CI: 0.04 to 0.08, p = 2.8 × 10 −8 ).
Conclusions
These data suggest that the BCAAs are not mediators of T2D risk but are biomarkers of diabetes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
- Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
- Meharry Medical College, Nashville, Tennessee, USA.
- Division of Cardiovascular Medicine, Department of Medicine, University of Michigan, Ann Arbor, Michigan, USA.
ORCID-Profile: Jonathan D Mosley, Venkatesh L Murthy, Jane F Ferguson
Förderung
- NHLBI NIH HHS
- NIDDK NIH HHS
- NIH HHS
- NIGMS NIH HHS
- National Institutes of Health
Zitieren
APA
Mosley, J. D., Shi, M., Agamasu, D., Vaitinadin, N. S., Murthy, V. L., Shah, R. V., Bagheri, M., & Ferguson, J. F. (2024). Branched‐chain amino acids and type 2 diabetes: a bidirectional Mendelian randomization analysis. Obesity, 32(2), 423-435. https://doi.org/10.1002/oby.23951
Vancouver
Mosley JD, Shi M, Agamasu D, Vaitinadin NS, Murthy VL, Shah RV, et al. Branched‐chain amino acids and type 2 diabetes: a bidirectional Mendelian randomization analysis. Obesity. 2024;32(2):423-435. doi:10.1002/oby.23951
BibTeX
@article{Mosley2024,
author = {Mosley, Jonathan D and Shi, Mingjian and Agamasu, David and Vaitinadin, Nataraja Sarma and Murthy, Venkatesh L and Shah, Ravi V and Bagheri, Minoo and Ferguson, Jane F},
title = {Branched‐chain amino acids and type 2 diabetes: a bidirectional Mendelian randomization analysis},
journal = {Obesity},
year = {2024},
volume = {32},
number = {2},
pages = {423--435},
doi = {10.1002/oby.23951}
}
EUVIMED